UK markets closed

Acurx Pharmaceuticals, Inc. (ACXP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.6900+0.1400 (+3.94%)
At close: 04:00PM EDT
3.8400 +0.15 (+4.07%)
After hours: 07:50PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
Operating expenses
Research development
2,757
2,030
2,203
3,510
Selling general and administrative
11,253
10,784
2,397
2,421
Total operating expenses
14,010
12,814
4,600
5,931
Operating income or loss
-14,010
-12,814
-4,600
-5,931
Total other income/expenses net
-
66.503
-
-
Income before tax
-13,944
-12,748
-4,600
-5,931
Income from continuing operations
-13,944
-12,748
-4,600
-5,931
Net income
-13,944
-12,748
-4,600
-5,931
Net income available to common shareholders
-13,944
-12,748
-4,600
-5,931
Basic EPS
-
-1.49
-0.74
-1.24
Diluted EPS
-
-1.49
-0.74
-1.24
Basic average shares
-
8,536
8,891
7,502
Diluted average shares
-
8,536
8,891
7,502
EBITDA
-
-12,814
-4,600
-5,931